PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$1.91
-0.05 (-2.55%)
▼
5d:
-2.55%
30d:
+11.05%
90d:
-16.96%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 46.9% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 46.9% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $1.91, which is considered slightly high relative to its 30-day fair value range of $1.75 to $1.94. From a valuation perspective, the stock is trading at a discount (Forward PE: 27.3) compared to its historical average (182.1). Remarkably, the market is currently pricing in an annual earnings decline of 46.9% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a strong downtrend. Immediate support is located at $1.62, while resistance sits at $2.27.
Market Sentiment: PETS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.15 (+12.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PETS is in a strong downtrend. Immediate support is located at $1.62, while resistance sits at $2.27.
Market Sentiment: PETS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.15 (+12.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.75 -
$1.94
Company Quality Score
59/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
69.0%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading below Wall St target ($2.15)
Trading Range Analysis
30-Day Trading Range
$1.75 -
$1.94
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.62
Resistance Level
$2.27
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.29
Wall Street Target
$2.15
(+12.6%)
Revenue Growth (YoY)
-15.6%
Earnings Growth (YoY)
266.7%
Profit Margin
-32.0%
Valuation Discount vs History
-46.9% cheaper
PE vs Historical
27.3 vs 182.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-46.9%
(market-implied from PE analysis)
1-Year Target
$1.72
(-10%)
2-Year Target
$1.55
(-19%)
3-Year Target
$1.39
(-27%)
3-Yr Target (if PE normalizes)
(PE: 27→182)
$9.29
(+387%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 27.3 to 182.1
Stabilization Target:
$12.75
(+567.4%)
PE Expansion Potential:
+567.4%
Share & Embed Analysis
Last updated: July 14, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$5 | 56 HOLD |
